Coronavirus information from UCLA and UCLA Health.


The Next Generation Incubator
Vivibaba specializes in protein delivery and advanced formulation of protein therapeutics. Their platform technology based on single-protein nanocapsules, which enables protein delivery with enhanced stability, reduced immunogenicity, prolonged circulation time, controlled release and targeting capability. Particularly, Vivibaba's technology can penetrate the BBB, enabling effective delivery of therapeutic proteins including nerve growth factors and monoclonal antibodies to the central nerve system (CNS) for neurodegeneration diseases, primary and metastatic brain cancer, spinal cord injury, and other diseases.

Graduated in 2020
Location: Los Angeles, CA